Efficacy of double-blind, placebo-controlled pramipexole against depression in Parkinson's disease

被引：0
|
作者：
Barone, P.
Poewe, W.
Tolosa, E.
Rascol, O.
Massey, D.
Debieuvre, C.
Albrecht, S.
机构：
来源：
MOVEMENT DISORDERS | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S347 / S347
页数：1
相关论文
共 50 条
  • [11] Effects of ETyrosine on Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
    DiFrancisco-Donoghue, Joanne
    Rabin, Ely
    Lamberg, Eric M.
    Werner, William G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2014, 1 (04): : 348 - 353
  • [12] A randomized, double-blind, placebo-controlled trial of hydrogen water in Parkinson's disease
    Yoritaka, A.
    Takanashi, M.
    Hirayama, M.
    Ohta, S.
    Hattori, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 311 - 311
  • [13] A randomized double-blind placebo-controlled trial of probiotics for constipation in Parkinson's disease
    Chong, K. K.
    Lim, S. Y.
    Manap, M. A. A. A.
    Lim, J. L.
    Low, S. C.
    Mahadeva, S. K.
    Tan, A. H.
    MOVEMENT DISORDERS, 2018, 33 : S194 - S194
  • [14] A Randomized, Double-Blind, Placebo-Controlled Trial of Levetiracetam for Dyskinesia in Parkinson's Disease
    Wong, Kitty K.
    Alty, Jane E.
    Goy, Amanda G.
    Raghav, Sanjay
    Reutens, David C.
    Kempster, Peter A.
    MOVEMENT DISORDERS, 2011, 26 (08) : 1552 - 1555
  • [15] A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
    Richard, I. H.
    McDermott, M. P.
    Kurlan, R.
    Lyness, J. M.
    Como, P. G.
    Pearson, N.
    Factor, S. A.
    Juncos, J.
    Ramos, C. Serrano
    Brodsky, M.
    Manning, C.
    Marsh, L.
    Shulman, L.
    Fernandez, H. H.
    Black, K. J.
    Panisset, M.
    Christine, C. W.
    Jiang, W.
    Singer, C.
    Horn, S.
    Pfeiffer, R.
    Rottenberg, D.
    Slevin, J.
    Elmer, L.
    Press, D.
    Hyson, H. C.
    McDonald, W.
    NEUROLOGY, 2012, 78 (16) : 1229 - 1236
  • [16] Transdermal rotigotine - Double-blind, placebo-controlled trial in Parkinson disease
    Jankovic, Joseph
    Watts, Ray L.
    Martin, Wayne
    Boroojerdi, Babak
    ARCHIVES OF NEUROLOGY, 2007, 64 (05) : 676 - 682
  • [17] A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease
    Jankovic, J
    Hunter, C
    PARKINSONISM & RELATED DISORDERS, 2002, 8 (04) : 271 - 276
  • [18] Sarizotan as a treatment for dyskinesias in Parkinson's disease:: A double-blind placebo-controlled trial
    Goetz, Christopher G.
    Damier, Philippe
    Hicking, Christine
    Laska, Eugene
    Mueller, Thomas
    Olanow, C. Warren
    Rascol, Olivier
    Russ, Hermann
    MOVEMENT DISORDERS, 2007, 22 (02) : 179 - 186
  • [19] A double-blind placebo-controlled study of the efficacy of a single dose of subcutaneous apomorphine in advanced Parkinson's disease
    Koller, W
    NEUROLOGY, 2004, 62 (07) : A329 - A329
  • [20] Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease
    Guttman, M
    Ott, E
    Tragner, H
    Bedard, PJ
    Pourcher, E
    Curran, T
    Goodridge, A
    Guttman, M
    Hobson, D
    King, D
    Martin, WRW
    Mendis, T
    Rajput, A
    Rivest, J
    Stoessl, J
    Suchowersky, O
    Moran, J
    Murphy, R
    Walsh, B
    ONeill, DO
    Klemperer, B
    Martin, M
    Oehlwein, C
    Polzer, U
    Reichmann, H
    Schimek, J
    Schlenker, M
    Schwartz, A
    Meier, D
    Traubner, P
    Benetin, J
    Bomhof, MAM
    Hovestadt, A
    Vreeling, FW
    Wolters, ECMJ
    Broddie, HG
    Clarke, C
    Clough, CJ
    Loizou, L
    Newman, PK
    Pye, IF
    NEUROLOGY, 1997, 49 (04) : 1060 - 1065
12345